GlassScriptPhysician profile
Michael Poulose
NPI 1740668227
$942.53
in general payments reported to CMS, 2019-2025
9 companies · $275 in 2025
The $275 reported for 2025 was more than what 88% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2021: $125 · 2022: $138 · 2023: $64.60 · 2024: $216 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $249.18 | 2021-2022 | |
| Ceribell, INC. | $149.78 | 2025 | Pocket Eeg Device |
| Pfizer INC. | $125.00 | 2019 | |
| Octapharma USA, INC. | $124.96 | 2025 | Balfaxar |
| Abbvie INC. | $112.94 | 2024 | |
| Smith+Nephew, INC. | $89.91 | 2024 | Regranex, Renasys Go V2 Home, Versajet |
| Janssen Pharmaceuticals, INC | $64.60 | 2023 | Xarelto |
| Cumberland Pharmaceuticals, INC. | $13.13 | 2024 | Caldolor |
| Chiesi USA, INC. | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Poulose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.